May 18, 2024
Mosquito Borne Disease Market

Mosquito Borne Disease Market to Exhibit Growth Due to Rising Incidences of Dengue and Zika Virus

Mosquito borne diseases have emerged as a major public health challenge across the globe owing to rising incidences of vector borne illnesses like dengue, malaria and Zika virus. The mosquito borne disease market primarily includes diagnostics tools and equipment for conditions such as dengue, malaria, chikungunya, yellow fever, West Nile virus, and more recently Zika virus. The global mosquito borne disease market is estimated to be valued at US$ 3.59 billion in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2030.

Mosquito borne illnesses are transmitted to humans through the bites of infected female mosquitoes. Common symptoms include fevers, rashes and joint pains. While malaria can often prove fatal if left untreated, the recent widespread outbreaks of dengue and Zika viruses across Latin America, the Caribbean, Southeast Asia and Africa have drawn global attention. Rising global temperatures and rainfall due to climate change have contributed to increased breeding of mosquitoes and incidence of transmission. Detection and prevention have thus become important to control the spread of such illnesses.

Key Takeaways

Key players operating in the Mosquito Borne Disease Market Size are Masimo, Medtronic Plc, Nihon-Kohden Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services, Inc.,Smiths Medical, Nonin, MICROTEK, OSI Systems, Inc. Honeywell International Inc., Promed Technology Co.Ltd., Beurer, Contec Medical Systems Co., Ltd., ChoiceMMed, CONMED Corporation, Stryker, Medline Industries, Inc., Curbell Medical Products, Inc., and Ecomed. Rising awareness regarding vector borne diseases and availability of advanced diagnostic methods present significant growth opportunities. Rapid population growth and increasing income levels in developing Asian and Latin American countries are expected to drive the demand for surveillance and early diagnostics.

Market drivers

The primary market driver is the rising incidences and prevalence of mosquito borne illnesses such as dengue, malaria and Zika globally, particularly in tropical and subtropical regions. According to WHO, there were around 228 million cases of malaria reported worldwide in 2018. Increasing temperatures and rainfall due to climate change have contributed to rapid breeding of mosquitoes and spread of these illnesses to new geographic regions including some temperate areas. Government initiatives to implement surveillance and control programs also promote greater use of diagnostics and screening. Development of novel point-of-care tests for rapid detection further support early treatment and management of such diseases.

PEST Analysis
Political: Governments and public health organizations play an active role in controlling the spread of mosquito-borne diseases through surveillance and vector control programs. Regulations regarding use of insecticides and drugs also have an impact.

Economic: Changes in income levels and investments towards healthcare influence demand for preventive and treatment products. Poverty is a major factor contributing to higher risk of infections.

Social: Travel and migration patterns affect the spread of diseases across regions. Social awareness regarding preventive measures plays a key role in curbing diseases.

Technological: Advancements in diagnostics, drugs and novel prevention technologies aid early detection and management. Devices with integrated data analytics are helping risk profiling and outbreak tracking.

The market in Asia Pacific region is currently the largest in terms of value due to several tropical and subtropical countries in the region that report high incidence of mosquito-borne diseases annually. North America is projected to be the fastest growing regional market during the forecast period supported by increased funding for development of innovative technologies for disease prevention and control.

Sub-Saharan Africa region accounts for highest disease burden where majority of the population still lacks access to basic healthcare. Growing rural to urban migration trends within several African nations are contributing to frequent outbreaks in new areas. Initiatives by global health organizations to strengthen surveillance and healthcare infrastructure could help reduce the social and economic impact.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it